Your browser doesn't support javascript.
loading
Immunity against Moraxella catarrhalis requires guanylate-binding proteins and caspase-11-NLRP3 inflammasomes.
Enosi Tuipulotu, Daniel; Feng, Shouya; Pandey, Abhimanu; Zhao, Anyang; Ngo, Chinh; Mathur, Anukriti; Lee, Jiwon; Shen, Cheng; Fox, Daniel; Xue, Yansong; Kay, Callum; Kirkby, Max; Lo Pilato, Jordan; Kaakoush, Nadeem O; Webb, Daryl; Rug, Melanie; Robertson, Avril Ab; Tessema, Melkamu B; Pang, Stanley; Degrandi, Daniel; Pfeffer, Klaus; Augustyniak, Daria; Blumenthal, Antje; Miosge, Lisa A; Brüstle, Anne; Yamamoto, Masahiro; Reading, Patrick C; Burgio, Gaetan; Man, Si Ming.
Afiliação
  • Enosi Tuipulotu D; Division of Immunology and Infectious Disease, The John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia.
  • Feng S; Division of Immunology and Infectious Disease, The John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia.
  • Pandey A; Division of Immunology and Infectious Disease, The John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia.
  • Zhao A; Division of Immunology and Infectious Disease, The John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia.
  • Ngo C; Division of Immunology and Infectious Disease, The John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia.
  • Mathur A; Division of Immunology and Infectious Disease, The John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia.
  • Lee J; Centre for Advanced Microscopy, The Australian National University, Canberra, ACT, Australia.
  • Shen C; Division of Immunology and Infectious Disease, The John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia.
  • Fox D; Division of Immunology and Infectious Disease, The John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia.
  • Xue Y; Division of Immunology and Infectious Disease, The John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia.
  • Kay C; Division of Immunology and Infectious Disease, The John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia.
  • Kirkby M; Division of Immunology and Infectious Disease, The John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia.
  • Lo Pilato J; Division of Immunology and Infectious Disease, The John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia.
  • Kaakoush NO; School of Medical Sciences, UNSW Sydney, Sydney, NSW, Australia.
  • Webb D; Centre for Advanced Microscopy, The Australian National University, Canberra, ACT, Australia.
  • Rug M; Centre for Advanced Microscopy, The Australian National University, Canberra, ACT, Australia.
  • Robertson AA; School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, QLD, Australia.
  • Tessema MB; Department of Microbiology and Immunology, The University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.
  • Pang S; Antimicrobial Resistance and Infectious Diseases (AMRID) Research Laboratory, Murdoch University, Murdoch, WA, Australia.
  • Degrandi D; Department of Microbiology, PathWest Laboratory Medicine-WA, Fiona Stanley Hospital, Murdoch, WA, Australia.
  • Pfeffer K; Institute of Medical Microbiology and Hospital Hygiene, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.
  • Augustyniak D; Institute of Medical Microbiology and Hospital Hygiene, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.
  • Blumenthal A; Department of Pathogen Biology and Immunology, Faculty of Biological Sciences, University of Wroclaw, Wroclaw, Poland.
  • Miosge LA; Frazer Institute, The University of Queensland, QLD, Brisbane, Australia.
  • Brüstle A; Division of Immunology and Infectious Disease, The John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia.
  • Yamamoto M; Division of Immunology and Infectious Disease, The John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia.
  • Reading PC; Department of Immunoparasitology, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan.
  • Burgio G; Laboratory of Immunoparasitology, WPI Immunology Frontier Research Center, Osaka University, Osaka, Japan.
  • Man SM; Department of Microbiology and Immunology, The University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.
EMBO J ; 42(6): e112558, 2023 03 15.
Article em En | MEDLINE | ID: mdl-36762431
ABSTRACT
Moraxella catarrhalis is an important human respiratory pathogen and a major causative agent of otitis media and chronic obstructive pulmonary disease. Toll-like receptors contribute to, but cannot fully account for, the complexity of the immune response seen in M. catarrhalis infection. Using primary mouse bone marrow-derived macrophages to examine the host response to M. catarrhalis infection, our global transcriptomic and targeted cytokine analyses revealed activation of immune signalling pathways by both membrane-bound and cytosolic pattern-recognition receptors. We show that M. catarrhalis and its outer membrane vesicles or lipooligosaccharide (LOS) can activate the cytosolic innate immune sensor caspase-4/11, gasdermin-D-dependent pyroptosis, and the NLRP3 inflammasome in human and mouse macrophages. This pathway is initiated by type I interferon signalling and guanylate-binding proteins (GBPs). We also show that inflammasomes and GBPs, particularly GBP2, are required for the host defence against M. catarrhalis in mice. Overall, our results reveal an essential role for the interferon-inflammasome axis in cytosolic recognition and immunity against M. catarrhalis, providing new molecular targets that may be used to mitigate pathological inflammation triggered by this pathogen.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Caspases / Inflamassomos Limite: Animals / Humans Idioma: En Revista: EMBO J Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Austrália

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Caspases / Inflamassomos Limite: Animals / Humans Idioma: En Revista: EMBO J Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Austrália